drug development

Manish Sharma led a clinical trial for a new antibody-drug conjugate that decreased tumor size in patients who had not responded to chemotherapy.

Clinical trial insights refine early-stage toxicology evaluations, yielding safer medicines.

Evaluating drug toxicity to development and reproduction is a critical component of drug safety assessment. 

Scientists and engineers teamed up to use robots to streamline cell therapy manufacturing, aiming to give more patients access to these lifesaving therapies.

Brain organoids serve as avatars for studying human neurobiology and advancing drug discovery for neurological disorders. 

By making peptides ring shaped, researchers uncovered a new class of drugs that is “just right” for previously undruggable targets.

Chemotherapy patients have reported cognitive impairments known as “chemobrain.” Now, researchers are closer to finding its cause and a potential treatment.

An understudied melanoma arises without sun exposure, but researchers are beginning to shed light on this challenging form of skin cancer. 

Artificial intelligence is helping researchers fill in critical gaps in medical treatment by identifying new drug targets for more precision medicine solutions.

The discovery of insulin and its role in diabetes began with extracting canine pancreatic secretions and culminated in the first artificial pancreas in 2016.